X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1935) 1935
Publication (143) 143
Newsletter (126) 126
Book Review (37) 37
Book Chapter (30) 30
Conference Proceeding (13) 13
Newspaper Article (10) 10
Dissertation (6) 6
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1315) 1315
index medicus (1193) 1193
neuromyelitis optica (1128) 1128
clinical neurology (902) 902
female (836) 836
multiple sclerosis (778) 778
neurosciences (701) 701
neuromyelitis-optica (664) 664
male (647) 647
adult (646) 646
multiple-sclerosis (613) 613
middle aged (540) 540
magnetic resonance imaging (494) 494
neurology (432) 432
aquaporins (408) 408
aquaporin 4 - immunology (339) 339
neuromyelitis optica - immunology (314) 314
research (312) 312
neuromyelitis optica - diagnosis (307) 307
diagnostic-criteria (287) 287
neuromyelitis optica - pathology (276) 276
immunology (270) 270
aquaporin-4 (267) 267
diagnosis (262) 262
adolescent (259) 259
antibodies (258) 258
young adult (243) 243
aged (233) 233
optic neuritis (232) 232
disease (224) 224
autoimmunity (218) 218
neuromyelitis (217) 217
spinal cord - pathology (212) 212
diagnosis, differential (206) 206
animals (204) 204
cerebrospinal-fluid (199) 199
autoantibodies - blood (192) 192
aquaporin 4 (189) 189
autoantibodies (186) 186
care and treatment (181) 181
cerebrospinal fluid (177) 177
child (171) 171
immunoglobulin g (170) 170
neuromyelitis optica - blood (169) 169
retrospective studies (168) 168
spinal cord (166) 166
lesions (163) 163
demyelination (162) 162
brain - pathology (158) 158
neuromyelitis optica - cerebrospinal fluid (154) 154
nmo (151) 151
mri (149) 149
transverse myelitis (149) 149
neuromyelitis optica - complications (148) 148
myelitis (147) 147
patients (147) 147
multiple sclerosis - diagnosis (145) 145
medical research (144) 144
analysis (140) 140
central nervous system (134) 134
multiple sclerosis - pathology (134) 134
marker (129) 129
neuromyelitis optica spectrum disorder (129) 129
brain (128) 128
medicine & public health (128) 128
pathogenesis (127) 127
multiple sclerosis - immunology (126) 126
immunoglobulins (124) 124
medicine, experimental (122) 122
neuromyelitis optica - drug therapy (122) 122
acute disseminated encephalomyelitis (120) 120
central-nervous-system (119) 119
nervous system (115) 115
nmo-igg (115) 115
autoantibodies - immunology (112) 112
nuclear magnetic resonance--nmr (112) 112
inflammation (109) 109
neuromyelitis optica spectrum disorders (109) 109
viral antibodies (108) 108
recurrence (106) 106
prognosis (102) 102
autoimmune diseases (100) 100
pediatrics (100) 100
anti-aquaporin-4 antibody (98) 98
health aspects (97) 97
development and progression (94) 94
disease progression (92) 92
neuromyelitis optica - physiopathology (92) 92
children (91) 91
pathology (91) 91
rituximab (91) 91
antibody (90) 90
risk factors (90) 90
spectrum (90) 90
immunoglobulin g - blood (89) 89
neuromyelitis optica - therapy (88) 88
psychiatry (87) 87
disorders (86) 86
article (85) 85
multiple sclerosis - cerebrospinal fluid (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1990) 1990
Japanese (29) 29
German (15) 15
Spanish (10) 10
French (9) 9
Chinese (8) 8
Czech (5) 5
Danish (3) 3
Korean (3) 3
Portuguese (2) 2
Russian (2) 2
Hungarian (1) 1
Norwegian (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 279
Background: Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) have been suggested to play a role in a subset of patients with neuromyelitis optica... 
Multiple sclerosis | Autoantibodies | Antibody index | Optic neuritis | Neuromyelitis optica antibodies (NMO-IgG) | Cerebrospinal fluid | Aquaporin-4 antibodies (AQP4-IgG) | Cell-based assays | Transverse Myelitis | Devic's syndrome | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Neuromyelitis optica (NMO) | Neuromyelitis optica spectrum disorders (NMOSD) | Longitudinally extensive transverse myelitis (LETM) | MEDUSA-HEAD ATAXIA | NEUROMYELITIS-OPTICA PHENOTYPE | SPECTRUM DISORDERS | IMMUNOLOGY | AQUAPORIN-4 ANTIBODIES | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | PURKINJE-CELL ANTIBODIES | EXPANDING SPECTRUM | NEUROSCIENCES | DIAGNOSTIC-CRITERIA | CEREBROSPINAL-FLUID ANALYSIS | Myelin-Oligodendrocyte Glycoprotein - immunology | Severity of Illness Index | Myelin-Oligodendrocyte Glycoprotein - genetics | Aquaporin 4 - immunology | Autoantibodies - blood | Humans | Neuromyelitis Optica - physiopathology | Male | Neuromyelitis Optica - blood | Neuromyelitis Optica - immunology | Autoantibodies - cerebrospinal fluid | Transfection | Myelitis - immunology | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Aquaporin 4 - genetics | Adult | Female | Immunoglobulin G | Physiological aspects | Development and progression | Genetic aspects | Neuromyelitis optica | Glycoproteins | Research
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 09/2016, Volume 13, Issue 1, p. 280
Background: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein... 
Aquaporin-4 antibodies (AQP4-IgG, NMO-IgG) | Therapy | Multiple sclerosis | Natalizumab | Optic neuritis | Vaccination | Electrophysiology | Infections | Longitudinally extensive transverse myelitis | Cerebrospinal fluid | Ofatumumab | Transverse myelitis | McDonald criteria | International consensus diagnostic criteria for neuromyelitis optica spectrum disorders | Evoked potentials | Methotrexate | Glatiramer acetate | Autoantibodies | Rituximab | Oligoclonal bands | Pregnancy | Treatment | Magnetic resonance imaging | Myelin oligodendrocyte glycoprotein antibodies (MOG-IgG) | Outcome | Interferon beta | Wingerchuk criteria 2006 and 2015 | IPND criteria | Neuromyelitis optica spectrum disorders (NMOSD) | Azathioprine | Barkhof criteria | Methotrexate Azathioprine | MEDUSA-HEAD ATAXIA | ANTIDIURETIC-HORMONE SECRETION | IMMUNOLOGY | MULTIPLE-SCLEROSIS | MYELIN-OLIGODENDROCYTE GLYCOPROTEIN | EXTENSIVE TRANSVERSE MYELITIS | PURKINJE-CELL ANTIBODIES | SPINAL-CORD BIOPSY | POSITIVE NEUROMYELITIS-OPTICA | PREGNANCY-RELATED RELAPSE | NEUROSCIENCES | OPTICA SPECTRUM DISORDER | Myelin-Oligodendrocyte Glycoprotein - immunology | Myelin-Oligodendrocyte Glycoprotein - genetics | Brain - diagnostic imaging | Age Distribution | Neuromyelitis Optica - therapy | Humans | Middle Aged | Cardiolipins - immunology | Male | Young Adult | Vaccination - methods | Neuromyelitis Optica - cerebrospinal fluid | HEK293 Cells | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Child | Optic Nerve - diagnostic imaging | Aquaporin 4 - immunology | Treatment Outcome | Neuromyelitis Optica - diagnostic imaging | Autoantibodies - cerebrospinal fluid | Adolescent | Sex Factors | Aged | Neuromyelitis Optica - epidemiology | Cohort Studies | Vision Disorders - etiology | Measurement | Care and treatment | Physiological aspects | Development and progression | Neuromyelitis optica | Diagnosis | Research
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e61835
Background: Differences in cytokine/chemokine profiles among patients with neuromyelitis optica (NMO), relapsing remitting multiple sclerosis (RRMS), and... 
RHEUMATOID-ARTHRITIS | CELLS | MESSENGER-RNA | MARKER | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | DISTINCT | T-HELPER TYPE-1 | DIAGNOSTIC-CRITERIA | SYNOVIAL-FLUIDS | Multiple Sclerosis, Chronic Progressive - cerebrospinal fluid | Recurrence | Aquaporin 4 - immunology | Chemokines - cerebrospinal fluid | Humans | Middle Aged | Male | Granulocyte-Macrophage Colony-Stimulating Factor - cerebrospinal fluid | Cytokines - cerebrospinal fluid | Interleukin-17 - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Adult | Female | Interleukin-6 - cerebrospinal fluid | Multiple Sclerosis, Relapsing-Remitting - cerebrospinal fluid | Development and progression | Neuromyelitis optica | Interleukins | T cells | Multiplexing | Neuroimaging | Immunoassay | Multiple sclerosis | Spinal cord | Disease | Carbon tetrachloride | Correlation coefficients | Interleukin | Central nervous system | Helper cells | Fluorescence | Lymphocytes T | Cerebrospinal fluid | Macrophages | Interleukin 6 | Proteins | Granulocyte colony-stimulating factor | Lymphocytes | Quality | Measurement methods | Colony-stimulating factor | Differential diagnosis | Growth factors | Immunoglobulins | Medical imaging | Psoriasis | Cytokines | Granulocyte-macrophage colony-stimulating factor | Colonies | Aquaporins | Neutrophils | CCL4 protein | Patients | Microglia | Neurological diseases | Neurology | Overexpression | Neuromyelitis | γ-Interferon | CXCL10 protein | Interferon | Chemokines | Monocyte chemoattractant protein 1
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2011, Volume 306, Issue 1, pp. 82 - 90
Journal Article
Neurology, ISSN 0028-3878, 07/2010, Volume 75, Issue 3, pp. 208 - 216
Introduction: Loss of aquaporin 4 and glial fibrillary acidic protein (GFAP) with necrosis and demyelination is a prominent pathologic feature of neuromyelitis... 
MULTIPLE-SCLEROSIS | NEUROMYELITIS-OPTICA | MARKER | FIBRILLARY ACIDIC PROTEIN | AQUAPORIN-4 | WATER CHANNEL | SERUM | ANTI-AQUAPORIN-4 ANTIBODY | CEREBROSPINAL-FLUID | DIAGNOSTIC-CRITERIA | CLINICAL NEUROLOGY | Myelin Basic Protein - cerebrospinal fluid | Neuroprotective Agents - therapeutic use | Neuromyelitis Optica - drug therapy | Follow-Up Studies | Methylprednisolone - therapeutic use | Humans | Middle Aged | Astrocytes - pathology | Demyelinating Diseases - cerebrospinal fluid | Central Nervous System - pathology | Male | Central Nervous System - immunology | Encephalomyelitis, Acute Disseminated - drug therapy | Glial Fibrillary Acidic Protein - cerebrospinal fluid | Neurofilament Proteins - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Nervous System Diseases - cerebrospinal fluid | Statistics, Nonparametric | Adult | Female | Nerve Growth Factors - cerebrospinal fluid | Demyelinating Diseases - drug therapy | Nervous System Diseases - pathology | Disability Evaluation | Encephalomyelitis, Acute Disseminated - cerebrospinal fluid | Demyelinating Diseases - blood | Aquaporin 4 - immunology | S100 Calcium Binding Protein beta Subunit | Multiple Sclerosis - cerebrospinal fluid | S100 Proteins - cerebrospinal fluid | Nervous System Diseases - drug therapy | Neuromyelitis Optica - pathology | Glial Fibrillary Acidic Protein - blood | Encephalomyelitis, Acute Disseminated - pathology | Multiple Sclerosis - pathology | Antibodies - blood | Aged | Biomarkers - cerebrospinal fluid | Astrocytes - metabolism
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0181758
Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are inflammatory diseases of the central nervous system. Although several studies... 
PATHOGENESIS | PROTON MR SPECTROSCOPY | N-ACETYLASPARTATE | MULTIDISCIPLINARY SCIENCES | MITOCHONDRIAL DYSFUNCTION | NMR-BASED METABOLOMICS | CEREBROSPINAL-FLUID | DIAGNOSTIC-CRITERIA | EXPRESSION | BRAIN | MYELIN LIPID-SYNTHESIS | Multivariate Analysis | Humans | Middle Aged | Male | Multiple Sclerosis - diagnostic imaging | Citric Acid - cerebrospinal fluid | Pyrrolidonecarboxylic Acid - cerebrospinal fluid | Acetone - cerebrospinal fluid | Glucose - cerebrospinal fluid | Proton Magnetic Resonance Spectroscopy - methods | Young Adult | Formates - cerebrospinal fluid | Neuromyelitis Optica - cerebrospinal fluid | Adult | Female | Acetates - cerebrospinal fluid | Child | Multiple Sclerosis - metabolism | Magnetic Resonance Spectroscopy - methods | Multiple Sclerosis - cerebrospinal fluid | Metabolome | Neuromyelitis Optica - metabolism | Neuromyelitis Optica - diagnostic imaging | Metabolomics - methods | Lactic Acid - cerebrospinal fluid | Adolescent | Aged | Hydroxybutyrates - cerebrospinal fluid | Multiple sclerosis | Usage | Analysis | Nuclear magnetic resonance spectroscopy | Neuromyelitis optica | Genetic aspects | Cerebrospinal fluid | Research | Risk factors | Brain | Energy metabolism | Nuclear magnetic resonance--NMR | Profiling | Central nervous system | Nervous system | Biosynthesis | Glucose | Inflammatory diseases | Alterations | Metabolites | Spectrum analysis | Remission | Isoleucine | Statistical analysis | Metabolism | Patients | Fatty acids | Citric acid | Neuromyelitis | Valine | Lactic acid | Acetic acid | Acetone | Nuclear magnetic resonance | NMR
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 12/2010, Volume 16, Issue 12, pp. 1443 - 1452
Journal Article